Marvell Technology, Inc. Other Income (Expense) decreased by 100.0% to $0.00 in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 100.0%, from -$1.92B to $0.00. Over 4 years (FY 2022 to FY 2026), Other Income (Expense) shows an upward trend with a 404.3% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$31.40M | -$1.70M | $1.00M | $34.80M | $5.20M | $3.70M | $3.20M | -$15.90M | -$49.90M | -$45.90M | -$41.20M | -$52.00M | -$45.50M | -$45.80M | -$47.70M | -$1.92B | -$54.70M | -$56.40M | $1.86B | $0.00 |
| QoQ Change | — | +94.6% | +158.8% | >999% | -85.1% | -28.8% | -13.5% | -596.9% | -213.8% | +8.0% | +10.2% | -26.2% | +12.5% | -0.7% | -4.1% | <-999% | +97.2% | -3.1% | >999% | -100.0% |
| YoY Change | — | — | — | — | +116.6% | +317.6% | +220.0% | -145.7% | <-999% | <-999% | <-999% | -227.0% | +8.8% | +0.2% | -15.8% | <-999% | -20.2% | -23.1% | >999% | +100.0% |